Cargando…

E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT

Epithelial-to-mesenchymal transition (EMT) is a step-wise process observed in normal and tumor cells leading to a switch from epithelial to mesenchymal phenotype. In tumors, EMT provides cancer cells with a metastatic phenotype characterized by E-cadherin down-regulation, cytoskeleton reorganization...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommariva, Michele, Gagliano, Nicoletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226001/
https://www.ncbi.nlm.nih.gov/pubmed/32331358
http://dx.doi.org/10.3390/cells9041040
_version_ 1783534185151987712
author Sommariva, Michele
Gagliano, Nicoletta
author_facet Sommariva, Michele
Gagliano, Nicoletta
author_sort Sommariva, Michele
collection PubMed
description Epithelial-to-mesenchymal transition (EMT) is a step-wise process observed in normal and tumor cells leading to a switch from epithelial to mesenchymal phenotype. In tumors, EMT provides cancer cells with a metastatic phenotype characterized by E-cadherin down-regulation, cytoskeleton reorganization, motile and invasive potential. E-cadherin down-regulation is known as a key event during EMT. However, E-cadherin expression can be influenced by the different experimental settings and environmental stimuli so that the paradigm of EMT based on the loss of E-cadherin determining tumor cell behavior and fate often becomes an open question. In this review, we aimed at focusing on some critical points in order to improve the knowledge of the dynamic role of epithelial cells plasticity in EMT and, specifically, address the role of E-cadherin as a marker for the EMT axis.
format Online
Article
Text
id pubmed-7226001
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72260012020-05-18 E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT Sommariva, Michele Gagliano, Nicoletta Cells Review Epithelial-to-mesenchymal transition (EMT) is a step-wise process observed in normal and tumor cells leading to a switch from epithelial to mesenchymal phenotype. In tumors, EMT provides cancer cells with a metastatic phenotype characterized by E-cadherin down-regulation, cytoskeleton reorganization, motile and invasive potential. E-cadherin down-regulation is known as a key event during EMT. However, E-cadherin expression can be influenced by the different experimental settings and environmental stimuli so that the paradigm of EMT based on the loss of E-cadherin determining tumor cell behavior and fate often becomes an open question. In this review, we aimed at focusing on some critical points in order to improve the knowledge of the dynamic role of epithelial cells plasticity in EMT and, specifically, address the role of E-cadherin as a marker for the EMT axis. MDPI 2020-04-22 /pmc/articles/PMC7226001/ /pubmed/32331358 http://dx.doi.org/10.3390/cells9041040 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sommariva, Michele
Gagliano, Nicoletta
E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
title E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
title_full E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
title_fullStr E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
title_full_unstemmed E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
title_short E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
title_sort e-cadherin in pancreatic ductal adenocarcinoma: a multifaceted actor during emt
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226001/
https://www.ncbi.nlm.nih.gov/pubmed/32331358
http://dx.doi.org/10.3390/cells9041040
work_keys_str_mv AT sommarivamichele ecadherininpancreaticductaladenocarcinomaamultifacetedactorduringemt
AT gaglianonicoletta ecadherininpancreaticductaladenocarcinomaamultifacetedactorduringemt